<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="the current promising approaches for the development of an effective" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) vaccine MirzaeiRasoulrasul.micro92@gmail.comab⁎MohammadzadehRokhsarehcMahdaviFarzaddBadrzadehFaribaeKazemiSheidafEbrahimiMehdigSoltaniFatemehhKazemiSimaaJedaAli SalimiiDarvishmotevalliMohammadjYousefimashoufRasoulaKeyvaniHosseinkeyvani.h@iums.ac.iri⁎KarampoorSajadsajadkarampour1987@gmail.comi⁎[a], [b], [c], [d],"/>
 <result pre="several countries. Abstract Coronavirus disease 2019 (COVID-19) is a pandemic" exact="infectious disease" post="caused by the novel coronavirus called SARS-CoV-2. There is"/>
 <result pre="Corona virus disease 2019 (COVID-19), also known as 2019-nCoV acute" exact="respiratory disease," post="is caused by SARS-CoV-2 that has led the current"/>
 <result pre="respiratory tract system and causes symptoms similar to those of" exact="common cold," post="including respiratory disorders, runny nose, dry cough, dizziness, sore"/>
 <result pre="and elderly individuals, COVID-19 symptoms can become more severe, causing" exact="pneumonia" post="and bronchitis [8]. The case fatality rate of this"/>
 <result pre="cases, a cytokine storm has been observed that causes the" exact="acute respiratory distress syndrome" post="[21], [22], [23]. Other reports on severe COVID-19 cases"/>
 <result pre="an overview of SARS-CoV-2 candidate vaccines. 5 Candidate vaccines for" exact="severe acute respiratory syndrome" post="Several approaches have been considered for the development of"/>
 <result pre="the immunogenicity of these vaccines as the decreased severity of" exact="pneumonia" post="and viral titer were reported [45]. Subunit vaccines are"/>
 <result pre="been found that the deletion of nsp-1 gene in murine" exact="hepatitis" post="virus can be used for the development of a"/>
 <result pre="several viral infections such as HIV (human immunodeficiency virus), Ebola," exact="hepatitis" post="C, rabies, as well as SARS, and the results"/>
 <result pre="caused by MERS candidate vaccines such as Chimpanzee-adenovirus and modified" exact="vaccinia virus" post="Ankara (Modified Vaccinia Ankara) were investigated. These vaccines induced"/>
 <result pre="of coronaviruses infection initially raised from studies on feline infectious" exact="peritonitis" post="virus (FIPV) [84]. FIPV infects myeloid-derived cells, such as"/>
 <result pre="vaccines that provide low titers of neutralizing antibodies led to" exact="peritonitis" post="and higher mortality rates in kittens [86]. Concerns were"/>
 <result pre="a principal target for vaccine development. 9 Ongoing vaccines for" exact="severe acute respiratory syndrome" post="coronavirus 2 Vaccines for acute viral infections are developed"/>
 <result pre="more challenging in the elderly as low efficacy of seasonal" exact="influenza" post="vaccines has been observed in this population [113]. By"/>
 <result pre="A promising effect has been indicated against viral pathogens, including" exact="yellow fever," post="herpes simplex virus, respiratory syncytial virus, and human papillomavirus"/>
 <result pre="effect has been indicated against viral pathogens, including yellow fever," exact="herpes simplex" post="virus, respiratory syncytial virus, and human papillomavirus [119]. Due"/>
 <result pre="live attenuated vaccine comprised of the causative agent of bovine" exact="tuberculosis" post="(Mycobacterium bovis). Amazingly, BCG vaccination seems to not only"/>
 <result pre="vaccination seems to not only protect humans against severe childhood" exact="tuberculosis" post="but has non-specific protective effects against other respiratory tract"/>
 <result pre="overly susceptible to COVID-19. One hypothesis is that antibodies against" exact="measles" post="(due to the MMR vaccine) may be cross-reactive with"/>
 <result pre="combined with survivin. IMV is currently evaluating DPX-Survivac in advanced" exact="ovarian cancer," post="as well as in combination therapy in various clinical"/>
 <result pre="induce immunity against this virus. CoroFlu will also display the" exact="influenza" post="virus hemagglutinin protein, which is the dominant influenza virus"/>
 <result pre="display the influenza virus hemagglutinin protein, which is the dominant" exact="influenza" post="virus antigen, so that immune responses will be induced"/>
 <result pre="that immune responses will be induced against both coronavirus and" exact="influenza" post="(H2N2 seasonal flu strain). [154] 10 Adjuvants Vaccine candidates"/>
 <result pre="the S protein of SARS-CoV-2, protected rhesus monkeys from developing" exact="pneumonia" post="[127]. This vaccine significantly diminished the viral loads in"/>
 <result pre="trial for the MERS-CoV vaccine [127]. An MVA-MERS-S (MVA: modified" exact="vaccinia virus" post="Ankara) DNA vaccine was safe, well-tolerated, and produced humoral"/>
 <result pre="The CpG 1018 adjuvant has been used in an FDA-approved" exact="hepatitis" post="B vaccine (HEPLISAV-B®) [127]. GlaxoSmithKline has also teamed up"/>
 <result pre="similar to the means employed for their approved Flublok recombinant" exact="influenza" post="virus vaccine [138], Sanofi's vaccine is also months, if"/>
 <result pre="to make vaccines accessible to the global population. Even for" exact="influenza" post="virus vaccines, for which many production facilities exist in"/>
 <result pre="94(4) (2020). 20LeungD.T.M.Chi HangT.F.Chun HungM.Sheung ChanP.K.CheungJ.L.K.NiuH.TamJ.S.L.LimP.L.Antibody response of patients with" exact="severe acute respiratory syndrome" post="(SARS) targets the viral nucleocapsidJ. Infect. Dis.1902200437938615216476 21HuangC.WangY.LiX.RenL.ZhaoJ.HuY.ZhangL.FanG.XuJ.GuX.Clinical features"/>
 <result pre="peripheral blood of 123 hospitalized patients with 2019 novel coronavirus" exact="pneumonia" post="(NCP)MedRxiv2020 25WangD.HuB.HuC.ZhuF.LiuX.ZhangJ.WangB.XiangH.ChengZ.XiongY.Clinical characteristics of 138 hospitalized patients with 2019"/>
 <result pre="25WangD.HuB.HuC.ZhuF.LiuX.ZhangJ.WangB.XiangH.ChengZ.XiongY.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected" exact="pneumonia" post="in Wuhan, ChinaJama32311202010611069 26QinC.ZhouL.HuZ.ZhangS.YangS.TaoY.XieC.MaK.ShangK.WangW.Dysregulation of immune response in patients"/>
 <result pre="33Navas-MartínS.WeissS.R.Coronavirus replication and pathogenesis: implications for the recent outbreak of" exact="severe acute respiratory syndrome" post="(SARS), and the challenge for vaccine developmentJ. Neurovirol.1022004758515204926 34XiongS.WangY.-F.ZhangM.-Y.LiuX.-J.ZhangC.-H.LiuS.-S.QianC.-W.LiJ.-X.LuJ.-H.WanZ.-Y.Immunogenicity"/>
 <result pre="vaccine protective in miceEmerg. Infect. Dis.1182005131216110580 39SeeR.H.ZakhartchoukA.N.PetricM.LawrenceD.J.MokC.P.HoganR.J.RoweT.ZitzowL.A.KarunakaranK.P.HittM.M.Comparative evaluation of two" exact="severe acute respiratory syndrome" post="(SARS) vaccine candidates in mice challenged with SARS coronavirusJ."/>
 <result pre="40LinJ.ZhangJ.-S.SuN.XuJ.-G.WangN.ChenJ.-T.ChenX.LiuY.-X.GaoH.JiaY.-P.Safety and immunogenicity from a phase I trial of inactivated" exact="severe acute respiratory syndrome" post="coronavirus vaccineAntiviral Therapy1272007110718018769 41RochaC.D.CaetanoB.C.MachadoA.V.Bruña-RomeroO.Recombinant viruses as tools to induce"/>
 <result pre="Immunol.9419975175249287173 44ImlerJ.-L.Adenovirus vectors as recombinant viral vaccinesVaccine13131995114311518578797 45KobingerG.P.FigueredoJ.M.RoweT.ZhiY.GaoG.SanmiguelJ.C.BellP.WivelN.A.ZitzowL.A.FliederD.B.Adenovirus-based vaccine prevents" exact="pneumonia" post="in ferrets challenged with the SARS coronavirus and stimulates"/>
 <result pre="receptor for the SARS coronavirusNature4266965200345045414647384 50OlsenC.W.A review of feline infectious" exact="peritonitis" post="virus: molecular biology, immunopathogenesis, clinical aspects, and vaccinationVet. Microbiol.361–219931378236772"/>
 <result pre="biology, immunopathogenesis, clinical aspects, and vaccinationVet. Microbiol.361–219931378236772 51AntónI.M.GonzálezS.BullidoM.J.CorsínM.RiscoC.LangeveldJ.P.EnjuanesL.Cooperation between transmissible" exact="gastroenteritis" post="coronavirus (TGEV) structural proteins in the in vitro induction"/>
 <result pre="and characterization of DNA vaccines targeting the nucleocapsid protein of" exact="severe acute respiratory syndrome" post="coronavirusJ. Virol.78920044638464515078946 54WangX.XuW.TongD.NiJ.GaoH.WangY.ChuY.LiP.YangX.XiongS.A chimeric multi-epitope DNA vaccine elicited specific"/>
 <result pre="a SARS-CoV nucleocapsid protein geneCell Mol. Immunol.36200645946517257500 58LamirandeE.W.DeDiegoM.L.RobertsA.JacksonJ.P.AlvarezE.SheahanT.ShiehW.-J.ZakiS.R.BaricR.EnjuanesL.A live attenuated" exact="severe acute respiratory syndrome" post="coronavirus is immunogenic and efficacious in golden Syrian hamstersJ."/>
 <result pre="protect mice from MERS-CoV infectionVaccine351220171586158928237499 75VolzA.KupkeA.SongF.JanyS.FuxR.Shams-EldinH.SchmidtJ.BeckerC.EickmannM.BeckerS.Protective efficacy of recombinant modified" exact="vaccinia virus" post="Ankara delivering Middle East respiratory syndrome coronavirus spike glycoproteinJ."/>
 <result pre="against enhancement in Zika virus infectionFront. Immunol.9201859729740424 81GouldE.A.BuckleyA.Antibody-dependent enhancement of" exact="yellow fever" post="and Japanese encephalitis virus neurovirulenceJ. General Virol.70Pt 6198916051608 82Martín-AcebesM.A.SaizJ.-C.Jiménez"/>
 <result pre="virus infectionFront. Immunol.9201859729740424 81GouldE.A.BuckleyA.Antibody-dependent enhancement of yellow fever and Japanese" exact="encephalitis" post="virus neurovirulenceJ. General Virol.70Pt 6198916051608 82Martín-AcebesM.A.SaizJ.-C.Jiménez de OyaN.Antibody-dependent enhancement"/>
 <result pre="Advances in virus researchElsevier2016193218 86VennemaH.De GrootR.HarbourD.DalderupM.Gruffydd-JonesT.HorzinekM.SpaanW.Early death after feline infectious" exact="peritonitis" post="virus challenge due to recombinant vaccinia virus immunizationJ. Virol.6431990140714092154621"/>
 <result pre="death after feline infectious peritonitis virus challenge due to recombinant" exact="vaccinia virus" post="immunizationJ. Virol.6431990140714092154621 87YipM.LeungH.LiP.CheungC.DutryI.LiD.DaeronM.BruzzoneR.PeirisJ.S.JaumeM.Antibody-dependent enhancement of SARS coronavirus infection and"/>
 <result pre="of suboptimal antibody responses in COVID-19Nat. Rev. Immunol.20201331792373 95BollesM.DemingD.LongK.AgnihothramS.WhitmoreA.FerrisM.FunkhouserW.GralinskiL.ToturaA.HeiseM.A double-inactivated" exact="severe acute respiratory syndrome" post="coronavirus vaccine provides incomplete protection in mice and induces"/>
 <result pre="response upon challengeJ. Virol.85232011122011221521937658 96YangZ.-Y.WernerH.C.KongW.-P.LeungK.TraggiaiE.LanzavecchiaA.NabelG.J.Evasion of antibody neutralization in emerging" exact="severe acute respiratory syndrome" post="coronavirusesProc. Natl. Acad. Sci.1023200579780115642942 97LuR.ZhaoX.LiJ.NiuP.YangB.WuH.WangW.SongH.HuangB.ZhuN.Genomic characterisation and epidemiology of"/>
 <result pre="Assessment of immunoreactive synthetic peptides from the structural proteins of" exact="severe acute respiratory syndrome" post="coronavirus, Clinical Chemistry 49(12) (2003) 1989-1996. 102TangF.QuanY.XinZ.-T.WrammertJ.MaM.-J.LvH.WangT.-B.YangH.RichardusJ.H.LiuW.Lack of peripheral"/>
 <result pre="105ChannappanavarR.FettC.ZhaoJ.MeyerholzD.K.PerlmanS.Virus-specific memory CD8 T cells provide substantial protection from lethal" exact="severe acute respiratory syndrome" post="coronavirus infectionJ. Virol.88192014110341104425056892 106DuL.HeY.ZhouY.LiuS.ZhengB.-J.JiangS.The spike protein of SARS-CoV–a target"/>
 <result pre="assay of the dynamic changes of serum antibody responses against" exact="severe acute respiratory syndrome" post="coronavirusChin. Med. J.1186200544645015788124 108XuX.GaoX.-M.Immunological responses against SARS-coronavirus infection in"/>
 <result pre="Mol. Immunol.12200411912216212898 109ZhongX.YangH.GuoZ.-F.SinW.-Y.F.ChenW.XuJ.FuL.WuJ.MakC.-K.G.ChengC.-S.S.B-cell responses in patients who have recovered from" exact="severe acute respiratory syndrome" post="target a dominant site in the S2 domain of"/>
 <result pre="Bushmaker, A. Flaxman, M. Ulaszewska, ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2" exact="pneumonia" post="in rhesus macaques, bioRxiv (2020). 133ZhuF.-C.LiY.-H.GuanX.-H.HouL.-H.WangW.-J.LiJ.-X.WuS.-P.WangB.-S.WangZ.WangL.Safety, tolerability, and immunogenicity"/>
 <result pre="non-randomised, first-in-human trialThe Lancet2020 134KochT.DahlkeC.FathiA.KupkeA.KrählingV.OkbaN.M.HalweS.RohdeC.EickmannM.VolzA.Safety and immunogenicity of a modified" exact="vaccinia virus" post="Ankara vector vaccine candidate for Middle East respiratory syndrome:"/>
 <result pre="AmerongenG.Geelhoed-MierasM.VerburghR.HeldensJ.BedwellJ.van den BrandJ.KuikenT.van BaalenC.A single immunization with CoVaccine HT-adjuvanted H5N1" exact="influenza" post="virus vaccine induces protective cellular and humoral immune responses"/>
</results>
